Microchip Detects Prostate Cancer Markers

Measuring devices that perform disease tests simply and quickly from small amounts of blood, urine, saliva, and other bodily fluids are extremely important for accurate diagnosis and verifying the effectiveness of therapeutic treatments. PSA of therapeutic treatments. PSA is a marker that increases in the blood as a result of prostate cancer. Marker screening of saliva is also carried out as a less-invasive form of cancer risk testing. A microscale testing chip that uses flexibly deforming nanosheets is formed using semiconductor micromachine technology to determine the presence or absence of disease.